| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |